Objective: Cardiac allograft arteriosclerosis, which limits long-term survival of recipients, cannot be prevented by conservative therapies. The arteriopathy is characterized by diffuse intimal thickening comprised of proliferative smooth muscle cells (SMCs). Cell death is a prominent feature of atherosclerosis; Bcl-x is one of the anti-apoptotic mediators. Methods: To test the hypothesis that antisense bcl-x oligodeoxynucleotide (ODN) is effective in preventing intimal hyperplasia through enhancing apoptosis after cardiac d transplantation, we performed single intraluminal delivery of antisense bcl-x ODN into murine cardiac allografts (n59). DBA / 2 (H-2 ) d hearts were transplanted into B10.D2 (H-2 ) mice. Sense bcl-x ODN (n58) and no treatment (n58) studies were also performed. Results: Allografts were harvested at 4 weeks after transplantation; all allografts kept beating throughout the period. Coronary intimal thickening had developed in nontreated and sense ODN transfected allografts at 4 weeks after transplantation with enhanced expression of Bcl-x and cell adhesion molecules, and suppressed apoptosis. However, antisense bcl-x ODN prevented neointimal formation through enhanced apoptosis. Conclusion: These results indicate that apoptosis of vascular SMCs induced by Bcl-x is associated with initial hyperplasia after heart transplantation. Antisense bcl-x ODN inhibits SMC proliferation by inducing apoptosis in graft coronary arteries.
Introduction
mal formation remains to be demonstrated. It is postulated that the regulation of apoptosis involves the balance Cardiac allograft arteriopathy is now the primary factor between pro-apoptotic mediators such as Bax, and antilimiting long-term survival of organ recipients [1] . Several apoptotic mediators such as Bcl-x [5] . Although the therapeutic trials have been performed in search of methprecise mechanisms by which Bcl-x prevents cell death ods to prevent this arteriopathy, which is characterized by remain to be further defined, recent studies indicate that diffuse intimal thickening comprised of proliferative Bcl-x inhibits caspase activation and alterations in mitosmooth muscle cells (SMCs), without significant success chondrial function associated with cell execution [6] . [2, 3] . Recent studies have documented that cell death is a However, the role of Bcl-x in the pathophysiology of prominent feature of atherosclerosis [4] , however the role cardiac allograft arteriopathy remains unelucidated. Reof apoptosis as a determinant of cardiac allograft neointicently, it was reported that antisense bcl-x ODN is an efficient therapeutic strategy for prevention of neointimal *Corresponding author. Present address: Vascular Medicine and formation after balloon injury of rat carotid arteries [7] . We irradiation (110 erg / mm / s) for 3 min just before use. The liposome suspension (0.5 ml, containing 10 mg of lipids) 2.5. Immunohistochemistry was mixed with HVJ (10 000 hemagglutinating units) in a total volume of 4 ml BSS. The mixture was incubated at Serial sections (6-8 mm) were cut and dipped in cold 48C for 5 min and then for 30 min at 378C while gently acetone for 10 min. Anti-Bcl-x (Transduction Lab. Lexshaking. Free HVJ was removed from the HVJ liposomes inton, KY), anti-Bax (Santa Cruz Biochem. Santa Cruz, by sucrose density gradient centrifugation [8] [9] [10] .
CA), anti-proliferating cell nuclear antigen (PCNA) (Santa Cruz), anti-ICAM-1 (YN1 / 1.7) and anti-VCAM-1 (MK / 2) 2.2. Murine cardiac transplantation and ex vivo gene monoclonal antibodies (mAbs) were used as primary transfer antibodies in this study; the sections were incubated with each antibody for 12 h at 48C. Antibody-biotin conjugate
Male DBA / 2 (H-2 ) and B10.D2 (H-2 ) mice (age 4-6 was detected with Vectastain ABC Kit (Vector Lab. Inc., weeks, 20-25 g) were obtained from Japan Charles River Burlingame, CA). Enzyme activity was detected with Laboratories (Tokyo, Japan). The phosphorothioate ODN diaminobenzidine (0.5 mg / ml) with 0.05% NiCl in 50 mM (15 mM) was injected (0.2 ml) into the descending aorta of Tris buffer. donor hearts just before transplantation and incubated for 10 min on ice. Efficiency of ex vivo transfection of ODN 2.6. Statistical analysis is more than 90% of graft cells [10] . After transfection, donor hearts were immediately transplanted into recipient All data are expressed as mean6S.D. Scoring of B10.D2 mice. Briefly, this technique involves anastomos-TUNEL assay and immunohistochemistry was as follows: ing the end of the donor aorta to the side of the recipient 0, no visible staining; 1, few cells with faint staining; 2, abdominal aorta, after which the donor pulmonary artery is moderate staining; and 3, intense diffuse staining [13, 14] . connected to the inferior vena cava of the recipient animal Percentages of intimal thickening and the scores were to return the myocardial blood flow. Ischemic time avercompared using a Scheffe's ANOVA. Values of P,0.05 aged 60 min and the overall success rate was greater than were considered significant. 90% [10] [11] [12] thickening had formed in the coronary arteries of sense allograft intima. Expression scores of PCNA and adhesion ODN transfected or untreated allograft recipients, however molecules were significantly different between the antiin recipients treated with antisense bcl-x ODN, arterial sense bcl-x ODN transfected group and other groups, neointimal formation was dramatically suppressed. The however, were not statistically different between sense scores between the antisense bcl-x ODN transfected and ODN and nontreated groups ( Table 1 , Fig. 2) . Intensity of other groups were statistically different, however the ICAM-1 or VCAM-1 expression in the myocardial interscores between the sense bcl-x ODN transfected and no stitium did not differ among the groups. Isografts were as treatment groups were not ( Table 1 , Fig. 1) .
free from Bax, Bcl-x, PCNA, ICAM-1 and VCAM-1 expression in the coronary arterial endothelium as native 3.2. TUNEL assay hearts.
Limited TUNEL positive cells were observed in the arterial thickened intima of allografts from nontreated or 4. Discussion sense bcl-x ODN-treated recipients. However, increased TUNEL positive cells were seen in the mildly thickened 4.1. Expression of Bcl-x in graft coronary arteries intima of the allografts treated with antisense bcl-x ODN. Scores of TUNEL positive cells were significantly differRecent studies have documented that cell death is a ent between the antisense bcl-x ODN transfected group prominent feature of atherosclerosis [4] , however, the role and other groups (Fig. 1, Table 1 ). We also transfected of apoptosis as a determinant of cardiac allograft neointiantisense bcl-x ODN into isografts to confirm the spemal formation remains to be demonstrated. It is postulated cificity. Medial vascular SMCs of the isografts absorbed that the regulation of apoptosis involves the balance the antisense bcl-x ODN, yet did not undergo apoptosis, between pro-apoptotic mediators such as Bax, and antiand were as free from TUNEL positive cells in the apoptotic mediators such as Bcl-x [6] [7] [8] . In this study, we coronary arterial endothelium as native hearts.
revealed that Bax is faintly expressed throughout the arterial thickened intima and media of nontreated allog-3.3. Immunohistochemistry rafts, while Bcl-x is more abundantly expressed within the arterial thickened intima, with enhanced PCNA expression. Bcl-x was strongly and diffusely expressed in the This observation is consistent with previous studies reportthickened intima of allograft arteries from nontreated or ing that intimal SMCs follow a proliferating pattern of sense ODN-treated recipients, while Bax expression was gene expression in association with alterations in the not enhanced. Antisense bcl-x ODN suppressed Bcl-x regulation of cell growth [16] . Alterations in the genetic expression in the endothelial cells in the mildly thickened program regulating intimal cell apoptosis may be a newly allograft intima, while Bax expression was not affected by defined pathogenic feature involved in the process of graft antisense bcl-x ODN. Expression scores of Bcl-x were arteriopathy. significantly different between the antisense bcl-x ODN transfected group and other groups, while the Bax scores 4.2. Antisense bcl-x ODN prevents neointimal formation were not statistically different among the groups. PCNA was enhanced in the thickened intima of nontreated or
To clarify the pathophysiological role of Bcl-x as a sense ODN-treated allografts, while antisense bcl-x ODN determinant of intimal cell death and neointimal formation, treatment limited PCNA expression. ICAM-1 and VCAMwe examined whether the downregulation of Bcl-x is 1 were expressed in the arterial thickened intima of the sufficient to selectively induce intimal cell apoptosis. allografts from nontreated or sense ODN-treated recipients, Recently, antisense bcl-x ODN has been shown to be an while antisense bcl-x ODN treatment suppressed these efficient therapeutic strategy for prevention of neointimal expression in the endothelial cells in the mildly thickened formation after balloon injury of rat carotid arteries [7] . We
